## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **TRUSTEES' REPORT FOR THE YEAR ENDED 31[ST] MARCH 2025**
## **Reference and Administrative Details of the Charity, its Trustees and Advisors**
There are three officers of the Association: The Chairman, The Honorary Secretary and The Honorary Treasurer. The Chairman is an ordinary member who is elected to office annually for a three-year term which can be extended by a further two years by the ordinary members at an Annual General Meeting; The Honorary Secretary and Honorary Treasurer are both ordinary members, elected by the ordinary members present at the Annual General Meeting; both serve until the next Annual General Meeting and are eligible for re-election up to a maximum term of five years. There is a one-year overlap between the final year of the current officer’s term of office, and the first year of the newly appointed officer (termed officer-elect for this period). This overlap period facilitates smooth transition between officer posts and their successors. The Association's Executive Committee consists of the three Officers of the Association (plus any officer-elects), plus nine ordinary members elected as described in the Rules. Provision is also made to co-opt member(s) where specific expertise is required. The President holds a non-executive position, is not a trustee and is elected for a four-year term.
For the accounting period the BACR Executive comprised of: Professor Adrian L Harris (President), Professor Ingunn Holen until December 2024, and Professor Kevin Ryan from January 2025 (Chair), Professor Charlotte Bevan (Honorary Secretary), Professor Joanne Edwards (Honorary Treasurer), William Brackenbrugy, Tim Fenton, Anita Grigoriadis, Jack Leslie, George Poulogiannis, Anna Wilkins, Giorgia Cioccoloni, Louise Fets and Mark Wade.
Newly elected trustees are supplied with documentation, obtained from the Charity Commission, outlining their responsibilities as trustees of the Charity. They, along with pre-existing trustees, are also regularly updated with Charity Commission News. The association is also a member of the National Council of Voluntary Organisations (NCVO) that keeps it informed of relevant voluntary sector and charity information.
## **Structure, Governance and Management**
The Association is constituted as an unincorporated association, and its governing document is its constitution. The BACR has a charitable registration number (289297) and its principal address during this reporting period was BACR Secretariat, c/o Leeds Institute of Medical Research, at, St. James’s Cancer Genetics Building, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF.
The Association maintains its own Secretariat: Mrs Janet Alexander (based within the Leeds Institute of Medical Research at St James) who was appointed as the BACR Administrative Secretary on 1[st] January 2010.
Applicable law requires the trustees to prepare for each financial year accounts that give a true and fair view of the state of affairs of the Association and the surplus or deficit of the Association for that period. In preparing those accounts the Trustees are required to:
- Select suitable accounting policies and then apply them consistently
- Make judgements and estimates which are reasonable
- Prepare the accounts on a going-concern basis unless it is inappropriate to presume that the Association will continue to operate
The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Association and to enable them to ensure that the accounts comply with the Charities Act, 2011. They are also responsible for safeguarding the assets of the Association and hence for taking reasonable steps for the prevention of and detection of fraud and other irregularities.
The BACR accounts are scrutinized annually by Independent Examiners; their report is appended to this trustees’ report. A resolution to appoint Independent Examiners ahead of the next financial year will be put forward to the membership by the Honorary Treasurer, at the 2025 AGM.
1
## **Objectives and Activities**
Under its Constitution, the Association's objects are for the promotion of the advance of research in relation to all aspects of cancer by encouraging the exchange of information. The policies adopted in furtherance of these are (i) the organising of meetings and workshops and (ii) the provision of funds to support BACR members in attending these and other such meetings. There has been no change in the remit of the BACR with respect to its activities during the reporting period.
## **Achievements and Performance**
During the reporting period the Association held the Response and Resistance in Cancer Therapy meeting at University of Kent, Canteburgy, on the 8[th] to 10[th] July 2024 and New Developments in Breast Cancer Research-From Lab to Clinic at the Glasshouse International Centre for Music, Gateshead on the 25[th] to 27[th] November 2024.
In the 2024-25 financial year the Association is delighted to announce that 44 awards worth a total of £47,673.67 were made to research students and established cancer researchers to present their work at international scientific conferences and visit overseas laboratories to learn new techniques. Some of these costs will be incurred during 2025-26 with a total of £38,867 being spent in the 2024-25 financial year.
## **Financial Review**
The principal funding source for the association is its capital investment and membership subscriptions. The investment portfolio is managed with an ethical concern that prohibits funds being invested in any tobacco or tobacco-related companies. The portfolio management company delivers an annual report to trustees with additional advice being delivered, also in the form of an annual report, by an independent financial advisor. The Association does not currently have any social programme related investments. On 31 March 2025, had a market value of £1,356,337.28.
In the course of its normal activities, the BACR recorded an operating deficit for the year of £3,690.
## **Plans for the Future**
The BACR 65[th] Annual meeting was held on the 2[nd] to 4[th] June 2025.
Looking ahead to 2025-26, the Association is hosting a Cancer immunology meeting which will be held on 10[th ] to 12[th] September 2025 at the University of Southampton. The BACR will also be hosting a Tumour Microenvironment conference which will include an Ex-vivo models for drug discovery Workshop by the NC3R from the 6[th] to 8[th] July 2026 in Nottingham and a Trailblazers in Cancer Research meeting which will be held in November 2026, the date has yet to be confirmed.
## **By order of the Executive Committee**
Professor Joanne Edwards, Honorary Treasurer, BACR,
2
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **Registered Charity No.289297**
## **Accounts for the period 1st April 2024 to 31st March 2025**
## **President**
Prof. Adrian Harris
## **Chair**
Prof. Kevin Ryan
## **Honorary Treasurer**
Prof. Joanne Edwards
## **Honorary Secretary**
Prof. Charlotte Bevan
## **Secretariat**
Janet Alexander Leeds Institute of Medical Research at St James's Cancer Genetics Building St James's University Hospital Beckett Street Leeds LS9 7TF
## **Bankers**
National Westminster Bank PLC 501 Silbury Boulevard Saxon Gate East Central Milton Keynes MK9 3ER
## **Independent Examiners**
UHY BPR Heaton Chartered Accountants Glenewes House, Gateway Drive Yeadon LS19 7XY
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **Contents of the**
## **Accounts for the period 1st April 2024 to 31st March 2025**
||Page|
|---|---|
|Trustees' Report|1|
|Independent Examiners' Report|3|
|Statement of Financial Activities|4|
|Balance Sheet|5|
|Notes to the Accounts|6|
|Income and Expenditure Account|9|
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **TRUSTEES' REPORT FOR THE YEAR ENDED 31[ST] MARCH 2025**
## **Reference and Administrative Details of the Charity, its Trustees and Advisors**
There are three officers of the Association: The Chairman, The Honorary Secretary and The Honorary Treasurer. The Chairman is an ordinary member who is elected to office annually for a three-year term which can be extended by a further two years by the ordinary members at an Annual General Meeting; The Honorary Secretary and Honorary Treasurer are both ordinary members, elected by the ordinary members present at the Annual General Meeting; both serve until the next Annual General Meeting and are eligible for re-election up to a maximum term of five years. There is a one-year overlap between the final year of the current officer’s term of office, and the first year of the newly appointed officer (termed officer-elect for this period). This overlap period facilitates smooth transition between officer posts and their successors. The Association's Executive Committee consists of the three Officers of the Association (plus any officer-elects), plus nine ordinary members elected as described in the Rules. Provision is also made to co-opt member(s) where specific expertise is required. The President holds a non-executive position, is not a trustee and is elected for a four-year term.
For the accounting period the BACR Executive comprised of: Professor Adrian L Harris (President), Professor Ingunn Holen until December 2024, and Professor Kevin Ryan from January 2025 (Chair), Professor Charlotte Bevan (Honorary Secretary), Professor Joanne Edwards (Honorary Treasurer), William Brackenbrugy, Tim Fenton, Anita Grigoriadis, Jack Leslie, George Poulogiannis, Anna Wilkins, Giorgia Cioccoloni, Louise Fets and Mark Wade.
Newly elected trustees are supplied with documentation, obtained from the Charity Commission, outlining their responsibilities as trustees of the Charity. They, along with pre-existing trustees, are also regularly updated with Charity Commission News. The association is also a member of the National Council of Voluntary Organisations (NCVO) that keeps it informed of relevant voluntary sector and charity information.
## **Structure, Governance and Management**
The Association is constituted as an unincorporated association, and its governing document is its constitution. The BACR has a charitable registration number (289297) and its principal address during this reporting period was BACR Secretariat, c/o Leeds Institute of Medical Research, at, St. James’s Cancer Genetics Building, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF.
The Association maintains its own Secretariat: Mrs Janet Alexander (based within the Leeds Institute of Medical Research at St James) who was appointed as the BACR Administrative Secretary on 1[st] January 2010.
Applicable law requires the trustees to prepare for each financial year accounts that give a true and fair view of the state of affairs of the Association and the surplus or deficit of the Association for that period. In preparing those accounts the Trustees are required to:
- Select suitable accounting policies and then apply them consistently
- Make judgements and estimates which are reasonable
- Prepare the accounts on a going-concern basis unless it is inappropriate to presume that the Association will continue to operate
The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Association and to enable them to ensure that the accounts comply with the Charities Act, 2011. They are also responsible for safeguarding the assets of the Association and hence for taking reasonable steps for the prevention of and detection of fraud and other irregularities.
The BACR accounts are scrutinized annually by Independent Examiners; their report is appended to this trustees’ report. A resolution to appoint Independent Examiners ahead of the next financial year will be put forward to the membership by the Honorary Treasurer, at the 2025 AGM.
1
## **Objectives and Activities**
Under its Constitution, the Association's objects are for the promotion of the advance of research in relation to all aspects of cancer by encouraging the exchange of information. The policies adopted in furtherance of these are (i) the organising of meetings and workshops and (ii) the provision of funds to support BACR members in attending these and other such meetings. There has been no change in the remit of the BACR with respect to its activities during the reporting period.
## **Achievements and Performance**
During the reporting period the Association held the Response and Resistance in Cancer Therapy meeting at University of Kent, Canteburgy, on the 8[th] to 10[th] July 2024 and New Developments in Breast Cancer Research-From Lab to Clinic at the Glasshouse International Centre for Music, Gateshead on the 25[th] to 27[th] November 2024.
In the 2024-25 financial year the Association is delighted to announce that 44 awards worth a total of £47,673.67 were made to research students and established cancer researchers to present their work at international scientific conferences and visit overseas laboratories to learn new techniques. Some of these costs will be incurred during 2025-26 with a total of £38,867 being spent in the 2024-25 financial year.
## **Financial Review**
The principal funding source for the association is its capital investment and membership subscriptions. The investment portfolio is managed with an ethical concern that prohibits funds being invested in any tobacco or tobacco-related companies. The portfolio management company delivers an annual report to trustees with additional advice being delivered, also in the form of an annual report, by an independent financial advisor. The Association does not currently have any social programme related investments. On 31 March 2025, had a market value of £1,356,337.28.
In the course of its normal activities, the BACR recorded an operating deficit for the year of £3,690.
## **Plans for the Future**
The BACR 65[th] Annual meeting was held on the 2[nd] to 4[th] June 2025.
Looking ahead to 2025-26, the Association is hosting a Cancer immunology meeting which will be held on 10[th ] to 12[th] September 2025 at the University of Southampton. The BACR will also be hosting a Tumour Microenvironment conference which will include an Ex-vivo models for drug discovery Workshop by the NC3R from the 6[th] to 8[th] July 2026 in Nottingham and a Trailblazers in Cancer Research meeting which will be held in November 2026, the date has yet to be confirmed.
## **By order of the Executive Committee**
Professor Joanne Edwards, Honorary Treasurer, BACR,
2
## **INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES OF THE**
## **BRITISH ASSOCIATION FOR CANCER RESEARCH (CHARITY NO. 289297)**
## **Independent examiner's report to the trustees of the British Association For Cancer Research**
I report to the charity trustees on my examination of the accounts of the British Association for Cancer Research (the trust) for year ended 31 March 2025.
## **Responsibilities and basis of report**
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable directions given by the charity commission under Section 145(5)(b) of the Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
1) accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
2) the accounts do not accord with those records; or
3) the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Stephen B Hinchcliffe ACA UHY BPR Heaton Chartered Accountants Glenewes House Gate Way Drive Leeds West Yorkshire LS19 7XY
Dated: 11 December 2025
3
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2025**
|**Note**
**Incoming resources**
From generated funds;
Voluntary income
Activities for generating funds
Investment income
From charitable activities
**Total incoming resources**
**Resources expended**
Costs of generating funds;
Costs of generating funds
Charitable activities
Governance costs
2
**Total resources expended**
**Net incoming/(outgoing) resources before transfers**
**Transfers**
Gross transfers between funds
**Net incoming/(outgoing) resources before**
**holding gains and losses**
Transfers between funds
Holding gains/(losses)-(realised and unrealised)
Gains/(losses) on investment assets
3
**Net movements in funds**
**Reconciliation of Funds**
Total funds brought forward
**Total funds carried forward**|**Restricted**
**Funds**
£
-
-
-
16,000|**Unrestricted**
**Funds**
£
5,134
81,071
33,498
49,579|**Total**
**Funds**
£
5,134
81,071
33,498
65,579|**Prior Period**
**Total Funds**
£
6,476
70,607
31,543
44,079|
|---|---|---|---|---|
||16,000|169,282|185,282|152,705|
||-
25,010
-|113,126
48,161
2,675|113,126
73,171
2,675|138,398
75,626
2,460|
||25,010|163,962|188,972|216,484|
||(9,010)
-|5,320
-|(3,690)
-|(63,779)
-|
||-
(9,010)
-|-
5,320
(6,286)|-
(3,690)
(6,286)|-
(63,779)
64,523|
||(9,010)
23,510|(966)
1,491,470|(9,976)
1,514,980|744
1,514,236|
||14,500|1,490,504|1,505,004|1,514,980|
4
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **BALANCE SHEET AS AT 31ST MARCH 2025**
|**Notes**
**FIXED ASSETS**
4
Investments
Intangible assets
Tangible assets
**CURRENT ASSETS**
Debtors
5
Cash at bank and in hand
6
**CREDITORS**
Amounts falling due within one year
7
**NET CURRENT ASSETS/ (LIABILITIES)**
**TOTAL ASSETS LESS CURRENT LIABILITIES**
**INCOME FUNDS**
Restricted funds
8
Unrestricted funds|**2025**
**£**
1,347,743
-
-
1,347,743
30,780
182,158
212,938
55,678
157,260
1,505,003
14,500
1,490,504
1,505,004|**2024**
**£**
1,104,029
-
-|
|---|---|---|
|||1,104,029|
|||7,030
448,169|
|||455,199
44,248|
|||410,951|
|||1,514,980|
|||23,510
1,491,470|
|||1,514,980|
The accounts were approved by the Honorary Treasurer on behalf of the Executive Committee.
Joanne Edwards - Honorary Treasurer
Dated: 11 December 2025
5
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025**
## 1. **ACCOUNTING POLICIES**
## **Basis of preparing the financial statements**
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the charity rounded to the nearest pound.
## **Income**
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
## **Expenditure**
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
## **Taxation**
The charity is exempt from tax on its charitable activities.
## **Fund Accounting**
The accounts include the results of the charities operations, which include unrestricted and restricted funds.
## Restricted funds
The association has the following restricted fund;
The AstraZeneca Fund, which combines the Tom Connors AstraZeneca Fund with the Frank Rose Fund. This fund provides support for both annual BACR AstraZeneca Young Scientist Frank Rose Award Lecture.
Movements in this fund are detailed in Note 8 to the accounts.
## **Fixed assets investments**
Investments are included at market value.
## **Tangible fixed assets and depreciation**
Fixtures and fittings are written off on a 15% reducing balance basis.
## **Intangible assets and amortisation**
The website development cost has been amortised in full.
## **Future meetings**
Payments made and income received in respect of meetings to be held in a future year are carried forward to be brought into account in the year in which the meetings are held.
## **Deficit and surpluses on joint meetings**
The association makes provision for the receipt, from third party organisers of meetings held during the year, and for payments to third party organisers for the Association's share of any deficits arising on such meetings, only when the sums involved can be accurately quantified, or have been either received or paid, as appropriate.
6
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025, continued**
|**2025**
£
**2. SUPPORT COSTS**
Committee travel expenses
Governance
155
Accountancy
Costs
2,520
University of Leeds - Employee costs
67,525
Bank and PayPal charges
701
70,901
**3 Investment gains/(losses)**
Market value carried forward
1,347,743
Funds invested in the year
(250,000)
Market value brought forward
(1,104,029)
Gain/(loss) for the year
(6,286)
**4. FIXED ASSETS**
**Investments**
Market Value at 1st April 2024
1,104,029
Acquisitions at cost
602,257
Disposals at cost
(372,343)
Gains/(losses) in the period
42,907
Unrealised gains/(losses) in the period
(52,815)
Market Value at 31st March 2025
1,324,035
Cash holding at 31st March 2025
23,708
1,347,743
Historical cost at 31st March 2025
1,128,528
The Association's investments are managed by Quilter Cheviot Limited.
**Intangible Assets - Website**
Cost at 1st April 2024 and 31st March 2025
20,304
Depreciation at 1st April 2024 and 31st March 2025
20,304
Net Book Value at 31st March 2025
-
**Tangible Assets**
Cost at 1st April 2024
-
Disposals in year
-
At 31 March 2025
-
Depreciation at 1st April 2024
-
Charge for period
-
Eliminated on disposal
-
Accumulated depreciation at 31st March 2025
-
Net Book Value at 31st March 2025
-
**Allocation**
50% Charitable activities|**2025**
£
**2. SUPPORT COSTS**
Committee travel expenses
Governance
155
Accountancy
Costs
2,520
University of Leeds - Employee costs
67,525
Bank and PayPal charges
701
70,901
**3 Investment gains/(losses)**
Market value carried forward
1,347,743
Funds invested in the year
(250,000)
Market value brought forward
(1,104,029)
Gain/(loss) for the year
(6,286)
**4. FIXED ASSETS**
**Investments**
Market Value at 1st April 2024
1,104,029
Acquisitions at cost
602,257
Disposals at cost
(372,343)
Gains/(losses) in the period
42,907
Unrealised gains/(losses) in the period
(52,815)
Market Value at 31st March 2025
1,324,035
Cash holding at 31st March 2025
23,708
1,347,743
Historical cost at 31st March 2025
1,128,528
The Association's investments are managed by Quilter Cheviot Limited.
**Intangible Assets - Website**
Cost at 1st April 2024 and 31st March 2025
20,304
Depreciation at 1st April 2024 and 31st March 2025
20,304
Net Book Value at 31st March 2025
-
**Tangible Assets**
Cost at 1st April 2024
-
Disposals in year
-
At 31 March 2025
-
Depreciation at 1st April 2024
-
Charge for period
-
Eliminated on disposal
-
Accumulated depreciation at 31st March 2025
-
Net Book Value at 31st March 2025
-
**Allocation**
50% Charitable activities|**2024**
£
-
2,460
82,162
973|
|---|---|---|
|||85,595|
|||1,104,029
-
(1,039,506)|
|||64,523|
|||1,004,987
100,201
(97,346)
157
78,017|
|||1,086,016
18,013|
|||1,104,029|
|||855,707|
|||20,304|
|||20,304|
|||-|
|||1,971
(1,971)|
|||-|
|||1,625
(1,625)|
|||-|
||-|-|
7
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025, continued**
|**5.**
**DEBTORS**
Prepayments and accrued income
**6.**
**CASH AT BANK**
Current account
Reserve account
**7.**
**CREDITORS: Amounts falling due within one year**
Creditors and accrued expenditure
**8.**
**RESTRICTED FUNDS**
Balance at 1st April 2024
Awards and costs
Balance at 31st March 2025|**2025**
£
30,780|**2024**
£
7,030|
|---|---|---|
||100
182,058|100
448,069|
||182,158|448,169|
||55,678|44,248|
||**Astra - Zeneca**
23,510
(9,010)|**Total**
23,510
(9,010)|
||14,500|14,500|
## **9. RELATED PARTY TRANSACTIONS**
The Charity is controlled by it's Trustees.
There have not been any material transactions with any related party during the year.
## **10. POST BALANCE SHEET EVENTS**
The market value of Investments stated in note 4 as at 2 December 2025 was in the sum of £1,464,327 including cash holdings of £24,463
8
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31ST MARCH 2025**
|**Income**
**Voluntary income**
Donations and Legacies
**Activities for generating funds**
Response and Resistance in Cancer Therapy
New Developments in Breast Cancer Research
Tumour Microenvironment and 3D Model Workshop
Trailblazers in Cancer Research
**Investment income**
Interest and dividends receivable
**From charitable activities**
Subscriptions
Astra Zeneca contribution to travel awards
Provisions no longer required
**Total income**
**Expenditure**
**Costs of generating funds**
BACR conferences
Recharged employee costs
EACR Membership
Printing, postage, stationery, advertising and publications
Bank and PayPal charges
**Charitable activities**
Travel awards and bursaries
National Council for Volunteer Organisations
Recharged employee costs
Bank and PayPal charges
**Governance costs**
Committee travel and other expenses
Accountancy
**Surplus/(deficit) for the year**|**Restricted**
**Funds**
£
-
-
-
-
-
-
-
16,000
-|**Unrestricted**
**Funds**
£
5,134
41,342
39,729
-
-
33,498
49,216
-
363|**Total**
**Funds**
£
5,134
41,342
39,729
-
-
33,498
49,216
16,000
363
185,282
67,942
33,763
8,072
2,999
351
38,867
191
33,763
351
155
2,520
188,972
(3,690)|**Prior Year**
**Total Funds**
£
6,476
-
-
49,946
20,661
31,543
43,532
-
547|
|---|---|---|---|---|
||16,000|169,282||152,705|
||-
-
-
-
-
25,010
-
-
-
-
-|67,942
33,763
8,072
2,999
351
13,857
191
33,763
351
155
2,520||85,515
41,081
7,649
3,666
487
33,880
179
41,081
487
-
2,460|
||25,010|163,962||216,484|
||(9,010)|5,320||(63,779)|
9
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **Registered Charity No.289297**
## **Accounts for the period 1st April 2024 to 31st March 2025**
## **President**
Prof. Adrian Harris
## **Chair**
Prof. Kevin Ryan
## **Honorary Treasurer**
Prof. Joanne Edwards
## **Honorary Secretary**
Prof. Charlotte Bevan
## **Secretariat**
Janet Alexander Leeds Institute of Medical Research at St James's Cancer Genetics Building St James's University Hospital Beckett Street Leeds LS9 7TF
## **Bankers**
National Westminster Bank PLC 501 Silbury Boulevard Saxon Gate East Central Milton Keynes MK9 3ER
## **Independent Examiners**
UHY BPR Heaton Chartered Accountants Glenewes House, Gateway Drive Yeadon LS19 7XY
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **Contents of the**
## **Accounts for the period 1st April 2024 to 31st March 2025**
||Page|
|---|---|
|Trustees' Report|1|
|Independent Examiners' Report|3|
|Statement of Financial Activities|4|
|Balance Sheet|5|
|Notes to the Accounts|6|
|Income and Expenditure Account|9|
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **TRUSTEES' REPORT FOR THE YEAR ENDED 31[ST] MARCH 2025**
## **Reference and Administrative Details of the Charity, its Trustees and Advisors**
There are three officers of the Association: The Chairman, The Honorary Secretary and The Honorary Treasurer. The Chairman is an ordinary member who is elected to office annually for a three-year term which can be extended by a further two years by the ordinary members at an Annual General Meeting; The Honorary Secretary and Honorary Treasurer are both ordinary members, elected by the ordinary members present at the Annual General Meeting; both serve until the next Annual General Meeting and are eligible for re-election up to a maximum term of five years. There is a one-year overlap between the final year of the current officer’s term of office, and the first year of the newly appointed officer (termed officer-elect for this period). This overlap period facilitates smooth transition between officer posts and their successors. The Association's Executive Committee consists of the three Officers of the Association (plus any officer-elects), plus nine ordinary members elected as described in the Rules. Provision is also made to co-opt member(s) where specific expertise is required. The President holds a non-executive position, is not a trustee and is elected for a four-year term.
For the accounting period the BACR Executive comprised of: Professor Adrian L Harris (President), Professor Ingunn Holen until December 2024, and Professor Kevin Ryan from January 2025 (Chair), Professor Charlotte Bevan (Honorary Secretary), Professor Joanne Edwards (Honorary Treasurer), William Brackenbrugy, Tim Fenton, Anita Grigoriadis, Jack Leslie, George Poulogiannis, Anna Wilkins, Giorgia Cioccoloni, Louise Fets and Mark Wade.
Newly elected trustees are supplied with documentation, obtained from the Charity Commission, outlining their responsibilities as trustees of the Charity. They, along with pre-existing trustees, are also regularly updated with Charity Commission News. The association is also a member of the National Council of Voluntary Organisations (NCVO) that keeps it informed of relevant voluntary sector and charity information.
## **Structure, Governance and Management**
The Association is constituted as an unincorporated association, and its governing document is its constitution. The BACR has a charitable registration number (289297) and its principal address during this reporting period was BACR Secretariat, c/o Leeds Institute of Medical Research, at, St. James’s Cancer Genetics Building, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF.
The Association maintains its own Secretariat: Mrs Janet Alexander (based within the Leeds Institute of Medical Research at St James) who was appointed as the BACR Administrative Secretary on 1[st] January 2010.
Applicable law requires the trustees to prepare for each financial year accounts that give a true and fair view of the state of affairs of the Association and the surplus or deficit of the Association for that period. In preparing those accounts the Trustees are required to:
- Select suitable accounting policies and then apply them consistently
- Make judgements and estimates which are reasonable
- Prepare the accounts on a going-concern basis unless it is inappropriate to presume that the Association will continue to operate
The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Association and to enable them to ensure that the accounts comply with the Charities Act, 2011. They are also responsible for safeguarding the assets of the Association and hence for taking reasonable steps for the prevention of and detection of fraud and other irregularities.
The BACR accounts are scrutinized annually by Independent Examiners; their report is appended to this trustees’ report. A resolution to appoint Independent Examiners ahead of the next financial year will be put forward to the membership by the Honorary Treasurer, at the 2025 AGM.
1
## **Objectives and Activities**
Under its Constitution, the Association's objects are for the promotion of the advance of research in relation to all aspects of cancer by encouraging the exchange of information. The policies adopted in furtherance of these are (i) the organising of meetings and workshops and (ii) the provision of funds to support BACR members in attending these and other such meetings. There has been no change in the remit of the BACR with respect to its activities during the reporting period.
## **Achievements and Performance**
During the reporting period the Association held the Response and Resistance in Cancer Therapy meeting at University of Kent, Canteburgy, on the 8[th] to 10[th] July 2024 and New Developments in Breast Cancer Research-From Lab to Clinic at the Glasshouse International Centre for Music, Gateshead on the 25[th] to 27[th] November 2024.
In the 2024-25 financial year the Association is delighted to announce that 44 awards worth a total of £47,673.67 were made to research students and established cancer researchers to present their work at international scientific conferences and visit overseas laboratories to learn new techniques. Some of these costs will be incurred during 2025-26 with a total of £38,867 being spent in the 2024-25 financial year.
## **Financial Review**
The principal funding source for the association is its capital investment and membership subscriptions. The investment portfolio is managed with an ethical concern that prohibits funds being invested in any tobacco or tobacco-related companies. The portfolio management company delivers an annual report to trustees with additional advice being delivered, also in the form of an annual report, by an independent financial advisor. The Association does not currently have any social programme related investments. On 31 March 2025, had a market value of £1,356,337.28.
In the course of its normal activities, the BACR recorded an operating deficit for the year of £3,690.
## **Plans for the Future**
The BACR 65[th] Annual meeting was held on the 2[nd] to 4[th] June 2025.
Looking ahead to 2025-26, the Association is hosting a Cancer immunology meeting which will be held on 10[th ] to 12[th] September 2025 at the University of Southampton. The BACR will also be hosting a Tumour Microenvironment conference which will include an Ex-vivo models for drug discovery Workshop by the NC3R from the 6[th] to 8[th] July 2026 in Nottingham and a Trailblazers in Cancer Research meeting which will be held in November 2026, the date has yet to be confirmed.
## **By order of the Executive Committee**
Professor Joanne Edwards, Honorary Treasurer, BACR,
2
## **INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES OF THE**
## **BRITISH ASSOCIATION FOR CANCER RESEARCH (CHARITY NO. 289297)**
## **Independent examiner's report to the trustees of the British Association For Cancer Research**
I report to the charity trustees on my examination of the accounts of the British Association for Cancer Research (the trust) for year ended 31 March 2025.
## **Responsibilities and basis of report**
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable directions given by the charity commission under Section 145(5)(b) of the Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
1) accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
2) the accounts do not accord with those records; or
3) the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Stephen B Hinchcliffe ACA UHY BPR Heaton Chartered Accountants Glenewes House Gate Way Drive Leeds West Yorkshire LS19 7XY
Dated: 11 December 2025
3
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2025**
|**Note**
**Incoming resources**
From generated funds;
Voluntary income
Activities for generating funds
Investment income
From charitable activities
**Total incoming resources**
**Resources expended**
Costs of generating funds;
Costs of generating funds
Charitable activities
Governance costs
2
**Total resources expended**
**Net incoming/(outgoing) resources before transfers**
**Transfers**
Gross transfers between funds
**Net incoming/(outgoing) resources before**
**holding gains and losses**
Transfers between funds
Holding gains/(losses)-(realised and unrealised)
Gains/(losses) on investment assets
3
**Net movements in funds**
**Reconciliation of Funds**
Total funds brought forward
**Total funds carried forward**|**Restricted**
**Funds**
£
-
-
-
16,000|**Unrestricted**
**Funds**
£
5,134
81,071
33,498
49,579|**Total**
**Funds**
£
5,134
81,071
33,498
65,579|**Prior Period**
**Total Funds**
£
6,476
70,607
31,543
44,079|
|---|---|---|---|---|
||16,000|169,282|185,282|152,705|
||-
25,010
-|113,126
48,161
2,675|113,126
73,171
2,675|138,398
75,626
2,460|
||25,010|163,962|188,972|216,484|
||(9,010)
-|5,320
-|(3,690)
-|(63,779)
-|
||-
(9,010)
-|-
5,320
(6,286)|-
(3,690)
(6,286)|-
(63,779)
64,523|
||(9,010)
23,510|(966)
1,491,470|(9,976)
1,514,980|744
1,514,236|
||14,500|1,490,504|1,505,004|1,514,980|
4
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **BALANCE SHEET AS AT 31ST MARCH 2025**
|**Notes**
**FIXED ASSETS**
4
Investments
Intangible assets
Tangible assets
**CURRENT ASSETS**
Debtors
5
Cash at bank and in hand
6
**CREDITORS**
Amounts falling due within one year
7
**NET CURRENT ASSETS/ (LIABILITIES)**
**TOTAL ASSETS LESS CURRENT LIABILITIES**
**INCOME FUNDS**
Restricted funds
8
Unrestricted funds|**2025**
**£**
1,347,743
-
-
1,347,743
30,780
182,158
212,938
55,678
157,260
1,505,003
14,500
1,490,504
1,505,004|**2024**
**£**
1,104,029
-
-|
|---|---|---|
|||1,104,029|
|||7,030
448,169|
|||455,199
44,248|
|||410,951|
|||1,514,980|
|||23,510
1,491,470|
|||1,514,980|
The accounts were approved by the Honorary Treasurer on behalf of the Executive Committee.
Joanne Edwards - Honorary Treasurer
Dated: 11 December 2025
5
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025**
## 1. **ACCOUNTING POLICIES**
## **Basis of preparing the financial statements**
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the charity rounded to the nearest pound.
## **Income**
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
## **Expenditure**
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
## **Taxation**
The charity is exempt from tax on its charitable activities.
## **Fund Accounting**
The accounts include the results of the charities operations, which include unrestricted and restricted funds.
## Restricted funds
The association has the following restricted fund;
The AstraZeneca Fund, which combines the Tom Connors AstraZeneca Fund with the Frank Rose Fund. This fund provides support for both annual BACR AstraZeneca Young Scientist Frank Rose Award Lecture.
Movements in this fund are detailed in Note 8 to the accounts.
## **Fixed assets investments**
Investments are included at market value.
## **Tangible fixed assets and depreciation**
Fixtures and fittings are written off on a 15% reducing balance basis.
## **Intangible assets and amortisation**
The website development cost has been amortised in full.
## **Future meetings**
Payments made and income received in respect of meetings to be held in a future year are carried forward to be brought into account in the year in which the meetings are held.
## **Deficit and surpluses on joint meetings**
The association makes provision for the receipt, from third party organisers of meetings held during the year, and for payments to third party organisers for the Association's share of any deficits arising on such meetings, only when the sums involved can be accurately quantified, or have been either received or paid, as appropriate.
6
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025, continued**
|**2025**
£
**2. SUPPORT COSTS**
Committee travel expenses
Governance
155
Accountancy
Costs
2,520
University of Leeds - Employee costs
67,525
Bank and PayPal charges
701
70,901
**3 Investment gains/(losses)**
Market value carried forward
1,347,743
Funds invested in the year
(250,000)
Market value brought forward
(1,104,029)
Gain/(loss) for the year
(6,286)
**4. FIXED ASSETS**
**Investments**
Market Value at 1st April 2024
1,104,029
Acquisitions at cost
602,257
Disposals at cost
(372,343)
Gains/(losses) in the period
42,907
Unrealised gains/(losses) in the period
(52,815)
Market Value at 31st March 2025
1,324,035
Cash holding at 31st March 2025
23,708
1,347,743
Historical cost at 31st March 2025
1,128,528
The Association's investments are managed by Quilter Cheviot Limited.
**Intangible Assets - Website**
Cost at 1st April 2024 and 31st March 2025
20,304
Depreciation at 1st April 2024 and 31st March 2025
20,304
Net Book Value at 31st March 2025
-
**Tangible Assets**
Cost at 1st April 2024
-
Disposals in year
-
At 31 March 2025
-
Depreciation at 1st April 2024
-
Charge for period
-
Eliminated on disposal
-
Accumulated depreciation at 31st March 2025
-
Net Book Value at 31st March 2025
-
**Allocation**
50% Charitable activities|**2025**
£
**2. SUPPORT COSTS**
Committee travel expenses
Governance
155
Accountancy
Costs
2,520
University of Leeds - Employee costs
67,525
Bank and PayPal charges
701
70,901
**3 Investment gains/(losses)**
Market value carried forward
1,347,743
Funds invested in the year
(250,000)
Market value brought forward
(1,104,029)
Gain/(loss) for the year
(6,286)
**4. FIXED ASSETS**
**Investments**
Market Value at 1st April 2024
1,104,029
Acquisitions at cost
602,257
Disposals at cost
(372,343)
Gains/(losses) in the period
42,907
Unrealised gains/(losses) in the period
(52,815)
Market Value at 31st March 2025
1,324,035
Cash holding at 31st March 2025
23,708
1,347,743
Historical cost at 31st March 2025
1,128,528
The Association's investments are managed by Quilter Cheviot Limited.
**Intangible Assets - Website**
Cost at 1st April 2024 and 31st March 2025
20,304
Depreciation at 1st April 2024 and 31st March 2025
20,304
Net Book Value at 31st March 2025
-
**Tangible Assets**
Cost at 1st April 2024
-
Disposals in year
-
At 31 March 2025
-
Depreciation at 1st April 2024
-
Charge for period
-
Eliminated on disposal
-
Accumulated depreciation at 31st March 2025
-
Net Book Value at 31st March 2025
-
**Allocation**
50% Charitable activities|**2024**
£
-
2,460
82,162
973|
|---|---|---|
|||85,595|
|||1,104,029
-
(1,039,506)|
|||64,523|
|||1,004,987
100,201
(97,346)
157
78,017|
|||1,086,016
18,013|
|||1,104,029|
|||855,707|
|||20,304|
|||20,304|
|||-|
|||1,971
(1,971)|
|||-|
|||1,625
(1,625)|
|||-|
||-|-|
7
**BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025, continued**
|**5.**
**DEBTORS**
Prepayments and accrued income
**6.**
**CASH AT BANK**
Current account
Reserve account
**7.**
**CREDITORS: Amounts falling due within one year**
Creditors and accrued expenditure
**8.**
**RESTRICTED FUNDS**
Balance at 1st April 2024
Awards and costs
Balance at 31st March 2025|**2025**
£
30,780|**2024**
£
7,030|
|---|---|---|
||100
182,058|100
448,069|
||182,158|448,169|
||55,678|44,248|
||**Astra - Zeneca**
23,510
(9,010)|**Total**
23,510
(9,010)|
||14,500|14,500|
## **9. RELATED PARTY TRANSACTIONS**
The Charity is controlled by it's Trustees.
There have not been any material transactions with any related party during the year.
## **10. POST BALANCE SHEET EVENTS**
The market value of Investments stated in note 4 as at 2 December 2025 was in the sum of £1,464,327 including cash holdings of £24,463
8
## **BRITISH ASSOCIATION FOR CANCER RESEARCH**
## **INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31ST MARCH 2025**
|**Income**
**Voluntary income**
Donations and Legacies
**Activities for generating funds**
Response and Resistance in Cancer Therapy
New Developments in Breast Cancer Research
Tumour Microenvironment and 3D Model Workshop
Trailblazers in Cancer Research
**Investment income**
Interest and dividends receivable
**From charitable activities**
Subscriptions
Astra Zeneca contribution to travel awards
Provisions no longer required
**Total income**
**Expenditure**
**Costs of generating funds**
BACR conferences
Recharged employee costs
EACR Membership
Printing, postage, stationery, advertising and publications
Bank and PayPal charges
**Charitable activities**
Travel awards and bursaries
National Council for Volunteer Organisations
Recharged employee costs
Bank and PayPal charges
**Governance costs**
Committee travel and other expenses
Accountancy
**Surplus/(deficit) for the year**|**Restricted**
**Funds**
£
-
-
-
-
-
-
-
16,000
-|**Unrestricted**
**Funds**
£
5,134
41,342
39,729
-
-
33,498
49,216
-
363|**Total**
**Funds**
£
5,134
41,342
39,729
-
-
33,498
49,216
16,000
363
185,282
67,942
33,763
8,072
2,999
351
38,867
191
33,763
351
155
2,520
188,972
(3,690)|**Prior Year**
**Total Funds**
£
6,476
-
-
49,946
20,661
31,543
43,532
-
547|
|---|---|---|---|---|
||16,000|169,282||152,705|
||-
-
-
-
-
25,010
-
-
-
-
-|67,942
33,763
8,072
2,999
351
13,857
191
33,763
351
155
2,520||85,515
41,081
7,649
3,666
487
33,880
179
41,081
487
-
2,460|
||25,010|163,962||216,484|
||(9,010)|5,320||(63,779)|
9